Top

Published in:

Open Access 01-12-2006 | Editorial

Open access and beyond

Authors: Shawn Mathur, Christian Schmidt, Chhaya Das, Philip W Tucker

Published in: Molecular Cancer | Issue 1/2006

Abstract

Uncensored exchange of scientific results hastens progress. Open Access does not stop at the removal of price and permission barriers; still, censorship and reading disabilities, to name a few, hamper access to information. Here, we invite the scientific community and the public to discuss new methods to distribute, store and manage literature in order to achieve unfettered access to literature.

Suber P: Open Access Overview. Focusing on open access to peer-reviewed research articles and their preprints. [http://www.earlham.edu/~peters/fos/overview.htm]

Eysenbach G: Citation advantage of Open Access articles. PLoS Biol. 2006, 4: e157- 10.1371/journal.pbio.0040157PubMedCentralCrossRefPubMed

Ippolito GC, Schmidt C, Das C, Tucker PW: Towards open access. Mol Cancer. 2005, 4: 20- 10.1186/1476-4598-4-20PubMedCentralCrossRefPubMed

Shadbolt N, Brody T, Carr L, Harnad S: The Open Research Web: A Preview of the Optimal and the Inevitable. [http://cogprints.org/4841/01/shad-bch.htm]

Jeffery KG: Open Access: an introduction. [http://www.ercim.org/publication/Ercim_News/enw64/jeffery.html

Public Library of Science: Open Access. [http://www.plos.org/oa/index.html]

BioMed Central's Open Access Charter. [http://www.biomedcentral.com/info/about/charter]

Bethesda Statement on Open Access Publishing. [http://www.pubmedcentral.nih.gov/about/openaccess.html]

About PloS Biology. [http://journals.plos.org/plosbiology/information.php]

10.

About BMC Biology. [http://www.biomedcentral.com/bmcbiol/about/

11.

About Nucleic Acids Research. [http://www.oxfordjournals.org/nar/about.html]

12.

About the Journal of Insect Science. [http://insectscience.org/about/]

13.

PubMed Central. [http://www.pubmedcentral.nih.gov/index.html]

14.

NCBI databases. [http://www.ncbi.nlm.nih.gov/entrez/]

Title: Open access and beyond
Authors: Shawn Mathur
Christian Schmidt
Chhaya Das
Philip W Tucker
Publication date: 01-12-2006
Publisher: BioMed Central
Published in: Molecular Cancer / Issue 1/2006
Electronic ISSN: 1476-4598
DOI: https://doi.org/10.1186/1476-4598-5-35

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2006

Down-regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors

Effect of ret/PTC 1 rearrangement on transcription and post-transcriptional regulation in a papillary thyroid carcinoma model

Myb proteins inhibit fibroblast transformation by v-Rel

Active Stat3 is required for survival of human squamous cell carcinoma cells in serum-free conditions

Stromal Derived Factor-1 (SDF-1/CXCL12) and CXCR4 in renal cell carcinoma metastasis

Valproic acid and butyrate induce apoptosis in human cancer cells through inhibition of gene expression of Akt/protein kinase B

Keynote webinar | Spotlight on antibody–drug conjugates in cancer